Intensified Short Course Regimen for TBM in Adults

NCT05917340 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

372

Enrollment

OTHER_GOV

Sponsor class

Conditions

Tuberculous Meningitis

Interventions

DRUG: High dose rifampicin (25mg/kg)
DRUG: Moxifloxacin 400mg
DRUG: Aspirin 150 mg
DRUG: Isoniazid
DRUG: Pyrazinamide
DRUG: Steroid
DRUG: Rifampicin
DRUG: HRZE
DRUG: HRE

Sponsor

Indian Council of Medical Research

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]